Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

CRT 2026: Key takeaways for interventional cardiologists
CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.
FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data
The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature.
Shortage of cardiac amyloidosis radiotracers should ease in late March
However, the regular supply of these imaging radiotracers may not be back online for another few months.
Cardiology now has more than 200 FDA-cleared AI algorithms
Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3.
FDA clears AI-enabled cardiac MR planning technology from Philips
The new SmartHeart technology automates 14 cardiac views in less than 30 seconds. It was designed to increase productivity and bring more consistency to cardiology and radiology departments.

The U.S. Food and Drug Administration (FDA) has granted UltraSight an expansion of its Echo Stewardship Platform compatibility with additional ultrasound system types. This enables deployment of artificial intelligence (AI) guidance for focused cardiac ultrasound (FoCUS) across an entire healthcare system without the need to buy new ultrasound systems. The move enables health systems to expand use of the AI on compatible equipment they already own, including handheld, laptop and cart-based systems.

FDA clears expanded use of AI that helps novice users perform echo exams

This update helps health systems get more value out of UltraSight's advanced AI technology—all without buying brand new ultrasound equipment.

Video interview with ASE President David Weiner explains goals of society in 2026. #ASE

ASE president outlines need to lead on AI, sustain echo workforce

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider.

Magic Magnetic Interventional Ablation Catheter

Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter

This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.

Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

FDA confirms new recall after catheter sheath was left in patient’s body

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

Lantheus completes sale of SPECT business

Lantheus has signaled that the decision to sell its SPECT business will allow the company to focus more on growing its portfolio of PET radiodiagnostics and microbubbles.

Trump regrets undergoing CT to evaluate heart health—cardiologist still baffled by his aspirin use

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

Cardiac Imaging

CRT 2026: Key takeaways for interventional cardiologists

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data

Shortage of cardiac amyloidosis radiotracers should ease in late March

Cardiology now has more than 200 FDA-cleared AI algorithms

FDA clears AI-enabled cardiac MR planning technology from Philips